Crisis Interventions for Pediatric Providers - Autism Version
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChildren's Hospital Los Angeles
About this trial
The goal of this clinical trial is to examine the initial feasibility, acceptability, and effectiveness of Crisis Interventions for Pediatric Providers - Autism version (CIPP-A) for providers serving autistic youth in outpatient settings. The main question aims to answer:
* Assess whether CIPP-A is feasible and acceptable to providers in development behavioral pediatric clinics? * Assess whether CIPP-A shows initial effectiveness in increasing providers confidence in managing suicide risk in autistic youth?
If there is a comparison group: Researchers will compare CIPP-A to general safety planning intervention (SPI) on feasibility, acceptability, and initial effectiveness.
Participants will be randomized to receive training in SPI or CIPP-A and complete online surveys and interviews over 6-months to measure feasibility, acceptability, and initial effectiveness.
Eligibility criteria
Qualifiers
Pediatric healthcare providers serving autistic youth in a DBP clinic in the U.S.
Willing and able to participate in the study and its activities, including remote training in either SPI or CIPP-A (depending on randomization)
Willing and able to provide informed consent
Comfortable speaking or communicating in English
Disqualifiers
Pediatric healthcare providers not serving autistic youth
Pediatric healthcare providers not practicing in a DBP clinic in the U.S.
Unwilling and unable to participate in the study and its activities
Unwilling and unable to provide informed consent
Trial design
Treatments tested in this trial
- Safety Planning Intervention
- Crisis Interventions for Pediatric Providers - Autism version (CIPP-A)
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Children's Hospital Los Angeles
Lead sponsor
Children's Hospital of Philadelphia
Collaborator
Source ClinicalTrials.gov